AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vigliptin M 1000mg/50mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Prevego Healthcare & Research Private Limited

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Vigliptin M 1000mg/50mg Tablet SR

The dual-action tablet Vigliptin M 1000mg/50mg SR effectively manages elevated blood glucose in individuals with type 2 diabetes, mitigating the risk of severe complications like renal impairment and vision loss. This medication may also lessen the probability of cardiovascular events such as stroke or myocardial infarction. Vigliptin M 1000mg/50mg SR may be administered independently or in conjunction with other antidiabetic therapies. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. This treatment actively regulates blood sugar, preventing future complications. Adherence to the prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Common adverse reactions include nausea, vomiting, diarrhea, abdominal distress, headache, pharyngitis, asthenia, gastroesophageal reflux, diaphoresis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management. This medication is not universally suitable. Prior to initiation, patients with pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption should inform their physician. Pregnant or lactating women require medical consultation before commencing treatment. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Renal function and blood glucose levels will be monitored by your doctor throughout therapy.

Uses of Vigliptin M 1000mg/50mg Tablet SR

Managing type 2 diabetes

Major Benefits of Vigliptin M 1000mg/50mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Vigliptin M 1000mg/50mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with a meal.

Common Side effects of Vigliptin M 1000mg/50mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vigliptin M 1000mg/50mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 1000mg/50mg Vigliptin M sustained-release tablet whole; avoid chewing, crushing, or fracturing. Consume this medication with food.

How Vigliptin M 1000mg/50mg Tablet SR works:

The extended-release tablet Vigliptin M 1000mg/50mg combines two antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vigliptin M 1000mg/50mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vigliptin M 1000mg/50mg sustained-release tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Vigliptin M 1000mg/50mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vigliptin M 1000mg/50mg SR tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Vigliptin M 1000mg/50mg sustained-release tablets is likely unsafe for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vigliptin M 1000mg/50mg Tablet SR :

Should you forget a dose of your Vigliptin M 1000mg/50mg sustained-release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Vigliptin M 1000mg/50mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vigliptin M 1000mg/50mg Tablet SR

Vigliptin M 1000mg/50mg SR tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Vigliptin M 1000mg/50mg Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vigliptin M 1000mg/50mg Tablet SR is contraindicated in patients with allergies to its components or excipients. It should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Vigliptin M 1000mg/50mg SR tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18 years of age.
Vigliptin M 1000mg/50mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vigliptin M 1000mg/50mg Tablet SR and seek immediate medical attention.
Prolonged use of Vigliptin M 1000mg/50mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Vigliptin M 1000mg/50mg SR Tablets are safe when taken as prescribed. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (especially if used with insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Vigliptin M 1000mg/50mg T...
147
MRP 170
13% off